May 2016

Alzheimer's 10th May To 11th May 2016, London, United Kingdom ( 8:00 am )

Alzheimer's  10th May to 11th May 2016, London, United Kingdom

SMi will present their inaugural conference on Alzheimer’s Disease 2016, which is one of the most threatening diseases that accompanies age, yet formidably mysterious in biology.

 

This conference will cover: Pre-clinical assessment criteria for AD diagnosis such as risk profiling, population group assessment and stages of AD progression. How do external stimuli play influence studies and outcome?

 

Furthermore, emerging frontiers in biomarker development to aid more accurate diagnosis and tracking of tau-mediated neuronal death will help further drug development as well as providing more answers into how AD occurs, and most importantly when.

 

The conference will gather leading researchers and clinical managers to discuss models, diagnostic imaging and novel therapeutic platforms.
 

For more info visit: http://www.alzheimers-conference.com/bioscreening

Url: http://www.alzheimers-conference.com/bioscreening

High Content & Phenotypic Screening 2016 On May 10-11 2016, Cambridge, UK ( 8:00 am )

High Content & Phenotypic Screening 2016 on May 10-11 2016, Cambridge, UK

This conference brings together researchers from both academia and industry, and will discuss the development of techniques and tools implemented in High Content technologies and Phenotypic Screening applications.

Hot topics to be covered include 3D cell based screening methods, high content screening and data management, the use of model organisms and novel approaches for phenotypic screening.

Attending this event will provide you with excellent opportunities for networking with attendees from big pharmaceutical and biotech companies, academia and government, helping you to find solutions and build collaborations.

Url: https://selectbiosciences.com/conferences/index.aspx?conf=HCPS2016

Alzheimer's 10th May To 11th May 2016, London, United Kingdom ( 8:00 am )

Alzheimer's  10th May to 11th May 2016, London, United Kingdom

SMi will present their inaugural conference on Alzheimer’s Disease 2016, which is one of the most threatening diseases that accompanies age, yet formidably mysterious in biology.

 

This conference will cover: Pre-clinical assessment criteria for AD diagnosis such as risk profiling, population group assessment and stages of AD progression. How do external stimuli play influence studies and outcome?

 

Furthermore, emerging frontiers in biomarker development to aid more accurate diagnosis and tracking of tau-mediated neuronal death will help further drug development as well as providing more answers into how AD occurs, and most importantly when.

 

The conference will gather leading researchers and clinical managers to discuss models, diagnostic imaging and novel therapeutic platforms.
 

For more info visit: http://www.alzheimers-conference.com/bioscreening

Url: http://www.alzheimers-conference.com/bioscreening

High Content & Phenotypic Screening 2016 On May 10-11 2016, Cambridge, UK ( 8:00 am )

High Content & Phenotypic Screening 2016 on May 10-11 2016, Cambridge, UK

This conference brings together researchers from both academia and industry, and will discuss the development of techniques and tools implemented in High Content technologies and Phenotypic Screening applications.

Hot topics to be covered include 3D cell based screening methods, high content screening and data management, the use of model organisms and novel approaches for phenotypic screening.

Attending this event will provide you with excellent opportunities for networking with attendees from big pharmaceutical and biotech companies, academia and government, helping you to find solutions and build collaborations.

Url: https://selectbiosciences.com/conferences/index.aspx?conf=HCPS2016

10th Drug Design & Medicinal Chemistry Conference May 11-12, 2016, Berlin, Germany ( 8:00 am )

10th Drug Design & Medicinal Chemistry Conference May 11-12, 2016, Berlin, Germany

We are excited to announce the 10th Drug Design & Medicinal Chemistry Conference, to be held May 11-12, 2016 in Berlin, Germany. This meeting will provide a multi-disciplinary forum for industry and academia colleagues to gather and explore the changing landscape of drug discovery in emerging target classes and chemical biology approaches for discovering new medicines. Leaders in the field will present on hot topics such as protein-protein interactions, overcoming resistance in drug design, allosteric inhibitors, and many more. Attendees will also have the opportunity to meet colleagues during dedicated networking sessions and form new connections.

Session topics include:

I. Targeting Protein-Protein Interactions
II. Chemogenomics and Chemical Biology for Target Identification and Validation
III. Novel Computational Methods
IV. Immmuno-oncology & Therapeutic Potential
V. Neuroprotective Drugs for the CNS & Blood Brain Barrier
VI. Kinase Inhibitor Design & Overcoming Resistance and Selectivity- Joint session with 2nd Kinase Inhibitors Design & Screening

Conference Dates: May 11-12, 2016

Url: https://www.gtcbio.com/conferences/drug-design-medicinal-chemistry-overview

10th Drug Design & Medicinal Chemistry Conference May 11-12, 2016, Berlin, Germany ( 8:00 am )

10th Drug Design & Medicinal Chemistry Conference May 11-12, 2016, Berlin, Germany

We are excited to announce the 10th Drug Design & Medicinal Chemistry Conference, to be held May 11-12, 2016 in Berlin, Germany. This meeting will provide a multi-disciplinary forum for industry and academia colleagues to gather and explore the changing landscape of drug discovery in emerging target classes and chemical biology approaches for discovering new medicines. Leaders in the field will present on hot topics such as protein-protein interactions, overcoming resistance in drug design, allosteric inhibitors, and many more. Attendees will also have the opportunity to meet colleagues during dedicated networking sessions and form new connections.

Session topics include:

I. Targeting Protein-Protein Interactions
II. Chemogenomics and Chemical Biology for Target Identification and Validation
III. Novel Computational Methods
IV. Immmuno-oncology & Therapeutic Potential
V. Neuroprotective Drugs for the CNS & Blood Brain Barrier
VI. Kinase Inhibitor Design & Overcoming Resistance and Selectivity- Joint session with 2nd Kinase Inhibitors Design & Screening

Conference Dates: May 11-12, 2016

Url: https://www.gtcbio.com/conferences/drug-design-medicinal-chemistry-overview

2nd Kinase Inhibitors Design & Screening Conference May 12-13, 2016, Berlin, Germany ( 8:00 am )

2nd Kinase Inhibitors Design & Screening Conference May 12-13, 2016, Berlin, Germany

GTCbio and the Advisory Board would like to invite you the 2nd Kinase Inhibitors Design & Screening Conference. This event takes place May 12-13, 2016 in Berlin, Germany. The conference brings together industry leaders from major pharmaceuticals, biotech companies, and top researchers from academia to provide a timely and critical update on significant kinase inhibitors and to better understand current trends for drug design and screening processes. This meeting’s discussion and presentations will circle around recent developments in allosteric kinase inhibitors, covalent inhibitor strategies, irreversible and RAF inhibitors, mechanisms of kinase inhibitor resistance, and mutation-focused approaches towards kinase inhibition.

Session topics include:

I. Novel Tools & Technological Advances in Kinase Inhibitor Development
II. Target Identification & Validation
III. Biomarkers in Kinase Drug Discovery
IV. Kinase Inhibitors for CNS Indications
V. Kinase Inhibitor Design & Overcoming Resistance and Selectivity- Joint session with 10th Drug Design & Medicinal Chemistry

Conference Dates: May 12-13, 2016

Url: https://www.gtcbio.com/conferences/kinase-inhibitors-design-screening-overview

2nd Kinase Inhibitors Design & Screening Conference May 12-13, 2016, Berlin, Germany ( 8:00 am )

2nd Kinase Inhibitors Design & Screening Conference May 12-13, 2016, Berlin, Germany

GTCbio and the Advisory Board would like to invite you the 2nd Kinase Inhibitors Design & Screening Conference. This event takes place May 12-13, 2016 in Berlin, Germany. The conference brings together industry leaders from major pharmaceuticals, biotech companies, and top researchers from academia to provide a timely and critical update on significant kinase inhibitors and to better understand current trends for drug design and screening processes. This meeting’s discussion and presentations will circle around recent developments in allosteric kinase inhibitors, covalent inhibitor strategies, irreversible and RAF inhibitors, mechanisms of kinase inhibitor resistance, and mutation-focused approaches towards kinase inhibition.

Session topics include:

I. Novel Tools & Technological Advances in Kinase Inhibitor Development
II. Target Identification & Validation
III. Biomarkers in Kinase Drug Discovery
IV. Kinase Inhibitors for CNS Indications
V. Kinase Inhibitor Design & Overcoming Resistance and Selectivity- Joint session with 10th Drug Design & Medicinal Chemistry

Conference Dates: May 12-13, 2016

Url: https://www.gtcbio.com/conferences/kinase-inhibitors-design-screening-overview

10th Annual Clinical Trial Logistics 2016 London On 18th & 19th May 2016 ( 8:00 am )

10th Annual Clinical Trial Logistics 2016 London on 18th & 19th May 2016

Registration is now live to attend the 10th annual Clinical Trial Logistics conference taking place in London on 18th & 19th May 2016.

The implementation of Annex 15 of the Good Manufacturing Practice in Autumn 2015 provided a huge change in the regulatory landscape of the rapidly growing clinical trial supplies industry, with logistics and distribution services accounting for the largest share of the market.

Clinical Trial Logistics 2016 will bring together leading industry professionals to discuss the latest regulatory developments, explore cost reduction, learn about logistical challenges in emerging markets, examine new innovations and examine best practices to ensure compliance of the new EU Clinical Trials Regulation which affects all parties in the clinical supply chain.

BENEFITS FOR ATTENDING:

* Gain key regulatory updated from Daiichi Sankyo and MHRA talking specifically on the development of the New EU Clinical Trials Regulation

* Discuss how to integrate forecasting and supply planning to an efficient clinical supply chain from GlaxoSmithKline

* Norgine presents how they ensure and maintain a successful contractor relationship

* Engage in discussions with Sanofi on visibility in the supply chain to fight counterfeiting

FEATURED EXPERT SPEAKERS INCLUDE:

* Graham McNaughton, Pharmaceutical Assessor, MHRA

* Elisabetta Carli, Head, Operations Clinical Vaccines Management, GlaxoSmithKline

* Tony Moult, Director, Clinical Supplies Ooperations, Daiichi Sankyo

* Geoffroy Bessaud, AVP, Anti-Counterfeiting Coordination, Sanofi

* Dawn Padfield, Director of Pharmaceutical Development and Clinical Supply, Norgine

* Elodie Fontaine, Clinical Trial Lead, Lundbeck

* Jasmine Hellwig, Senior Comparator Specialist, Merck Sharpe and Dohme

* Abdulkareem Ghanayem, Clinical Trial Operations Project Manager, Takeda

HOW TO BOOK:

Book by 29th February to save £400 and benefit from the best price.

Register online here.

www.clinical-trial-logistics.com/bioscreening

Url: http://www.clinical-trial-logistics.com/bioscreening

10th Annual Clinical Trial Logistics 2016 London On 18th & 19th May 2016 ( 8:00 am )

10th Annual Clinical Trial Logistics 2016 London on 18th & 19th May 2016

Registration is now live to attend the 10th annual Clinical Trial Logistics conference taking place in London on 18th & 19th May 2016.

The implementation of Annex 15 of the Good Manufacturing Practice in Autumn 2015 provided a huge change in the regulatory landscape of the rapidly growing clinical trial supplies industry, with logistics and distribution services accounting for the largest share of the market.

Clinical Trial Logistics 2016 will bring together leading industry professionals to discuss the latest regulatory developments, explore cost reduction, learn about logistical challenges in emerging markets, examine new innovations and examine best practices to ensure compliance of the new EU Clinical Trials Regulation which affects all parties in the clinical supply chain.

BENEFITS FOR ATTENDING:

* Gain key regulatory updated from Daiichi Sankyo and MHRA talking specifically on the development of the New EU Clinical Trials Regulation

* Discuss how to integrate forecasting and supply planning to an efficient clinical supply chain from GlaxoSmithKline

* Norgine presents how they ensure and maintain a successful contractor relationship

* Engage in discussions with Sanofi on visibility in the supply chain to fight counterfeiting

FEATURED EXPERT SPEAKERS INCLUDE:

* Graham McNaughton, Pharmaceutical Assessor, MHRA

* Elisabetta Carli, Head, Operations Clinical Vaccines Management, GlaxoSmithKline

* Tony Moult, Director, Clinical Supplies Ooperations, Daiichi Sankyo

* Geoffroy Bessaud, AVP, Anti-Counterfeiting Coordination, Sanofi

* Dawn Padfield, Director of Pharmaceutical Development and Clinical Supply, Norgine

* Elodie Fontaine, Clinical Trial Lead, Lundbeck

* Jasmine Hellwig, Senior Comparator Specialist, Merck Sharpe and Dohme

* Abdulkareem Ghanayem, Clinical Trial Operations Project Manager, Takeda

HOW TO BOOK:

Book by 29th February to save £400 and benefit from the best price.

Register online here.

www.clinical-trial-logistics.com/bioscreening

Url: http://www.clinical-trial-logistics.com/bioscreening

5th Annual ADC Summit London On May 23-24 2016 ( 8:00 am )

5th annual ADC Summit London on May 23-24, 2016

SMi's 5th annual ADC Summit provides a comprehensive analysis of the various approaches with the next generation ADCs. Hear the latest insights from Takeda on Adcetris; discuss the latest advancements in research and development from Medimmune; and analyse case studies from big pharma companies such as Roche, Bayer, Pfizer, AstraZeneca, Novartis and many more.

Join industry experts as they share, confer and debate how to create the next wave of ADCs with better efficacy, lower toxicity and improved potency for clinical success.

Register for 2 half-day post-conference workshops

WORKSHOP A: ADC Payloads: Availability and Mechanisms of Action hosted by Femtogenix and King’s College London

WORKSHOP B: Developments in High Potency Manufacturing hosted by SKAN AG

For more information or to register visit http://www.adcsummit.com/bioscreening

Url: http://www.adcsummit.com/bioscreening

Pain Therapeutics May 23-24 2016, London, UK ( 8:00 am )

Pain Therapeutics May 23-24 2016, London, UK

Many research studies show, pain is a significant source of suffering for many people and seriously affects their quality of life. Treatment of these patients is a great challenge and requires special approaches.

SMi is proud to present the return of 16th Annual Pain Therapeutics to London, UK on 23-24 of May 2016. Through a series of interactive presentations and panel discussions, the event will introduce the insights from key industry leaders, outlining the current activities, key issues and trends in pain medicine. This event will bring highlights of research and development in the pain relief field as well as new models and innovation of overcoming issues in the niche market.

For more info visit: www.pain-therapeutics.co.uk/bioscreening

Url: http://www.pain-therapeutics.co.uk/bioscreening

5th Annual ADC Summit London On May 23-24 2016 ( 8:00 am )

5th annual ADC Summit London on May 23-24, 2016

SMi's 5th annual ADC Summit provides a comprehensive analysis of the various approaches with the next generation ADCs. Hear the latest insights from Takeda on Adcetris; discuss the latest advancements in research and development from Medimmune; and analyse case studies from big pharma companies such as Roche, Bayer, Pfizer, AstraZeneca, Novartis and many more.

Join industry experts as they share, confer and debate how to create the next wave of ADCs with better efficacy, lower toxicity and improved potency for clinical success.

Register for 2 half-day post-conference workshops

WORKSHOP A: ADC Payloads: Availability and Mechanisms of Action hosted by Femtogenix and King’s College London

WORKSHOP B: Developments in High Potency Manufacturing hosted by SKAN AG

For more information or to register visit http://www.adcsummit.com/bioscreening

Url: http://www.adcsummit.com/bioscreening

Pain Therapeutics May 23-24 2016, London, UK ( 8:00 am )

Pain Therapeutics May 23-24 2016, London, UK

Many research studies show, pain is a significant source of suffering for many people and seriously affects their quality of life. Treatment of these patients is a great challenge and requires special approaches.

SMi is proud to present the return of 16th Annual Pain Therapeutics to London, UK on 23-24 of May 2016. Through a series of interactive presentations and panel discussions, the event will introduce the insights from key industry leaders, outlining the current activities, key issues and trends in pain medicine. This event will bring highlights of research and development in the pain relief field as well as new models and innovation of overcoming issues in the niche market.

For more info visit: www.pain-therapeutics.co.uk/bioscreening

Url: http://www.pain-therapeutics.co.uk/bioscreening

3rd Metabolomics - Advances & Applications In Human Disease Conference May 25-26, 2016, Boston, MA ( 9:00 am )

3rd Metabolomics - Advances & Applications in Human Disease Conference May 25-26, 2016, Boston, MA

GTCbio is proud to present the 3rd Metabolomics - Advances & Applications in Human Disease Conference, which will be part of The Genomics & Big Data Summit and takes place May 25-26, 2016 in Boston, MA.

There is still significant human variability in metabolite identification for targets and pathways. These challenges affect the advancement in biomarker development, mass spectrometry-cased imaging, big data, and the application of metabolomics for drug discovery and development.

Join us for an event that presents new research and offers networking opportunities with the researchers and scientists who are working on developing clinical assays, connecting the metabolome and the genome, and establishing common quality standards for experimental data

Sessions include:

I. Advances in Metabolite Markers - Discovery and Validation
II. Imaging and Computational Approaches to Assessing the Metabolome
III. Metabolite Identification - Targets and Pathways
IV. Bioinformatics for Metabolomics: Current Status and Future Directions
V. Translating Metabolomics Discoveries in Clinical Practice
We hope to see you there!

Conference Dates: May 25-26, 2016

Conference Link: http://www.gtcbio.com/metabolomics

Url: http://www.gtcbio.com/metabolomics

3rd Metabolomics - Advances & Applications In Human Disease Conference May 25-26, 2016, Boston, MA ( 9:00 am )

3rd Metabolomics - Advances & Applications in Human Disease Conference May 25-26, 2016, Boston, MA

GTCbio is proud to present the 3rd Metabolomics - Advances & Applications in Human Disease Conference, which will be part of The Genomics & Big Data Summit and takes place May 25-26, 2016 in Boston, MA.

There is still significant human variability in metabolite identification for targets and pathways. These challenges affect the advancement in biomarker development, mass spectrometry-cased imaging, big data, and the application of metabolomics for drug discovery and development.

Join us for an event that presents new research and offers networking opportunities with the researchers and scientists who are working on developing clinical assays, connecting the metabolome and the genome, and establishing common quality standards for experimental data

Sessions include:

I. Advances in Metabolite Markers - Discovery and Validation
II. Imaging and Computational Approaches to Assessing the Metabolome
III. Metabolite Identification - Targets and Pathways
IV. Bioinformatics for Metabolomics: Current Status and Future Directions
V. Translating Metabolomics Discoveries in Clinical Practice
We hope to see you there!

Conference Dates: May 25-26, 2016

Conference Link: http://www.gtcbio.com/metabolomics

Url: http://www.gtcbio.com/metabolomics

CRISPR & Genome Engineering Conference May 26-27, 2016, Boston, MA ( 9:00 am )

CRISPR & Genome Engineering Conference May 26-27, 2016, Boston, MA

On behalf of GTCbio and the 2016 Advisory Board, you are invited to the CRISPR & Genome Engineering Conference which takes place May 26-27, 2016 in Boston, MA. This meeting is part of The Genomics & Big Data Summit and will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and discuss the most recent advances in CRISPR & Genome Engineering.

Leading researchers will present on hot topics such as: therapeutic applications of CRISPR and genome engineering, discovery and mechanisms of CRISPR systems, and will discuss updates on current CRISPR technologies and techniques. In addition to scientific talks, dedicated networking sessions will allow attendees to better dialogue on how CRISPR & Genome

Engineering will continue to impact biomedical research.

Sessions include:

I. Therapeutic Applications of CRISPR & Genome Engineering
II. Advances in CRISPR-Cas9 Specificity
III. Discovery and Mechanisms of CRISPR Systems
IV. Update: Current CRISPR Technologies & Techniques
V. CRISPR Regulation of Gene Expression
We look forward to seeing you at the conference!

Conference Dates: May 26-27, 2016

Conference Link: http://www.gtcbio.com/CRISPR

Url: http://www.gtcbio.com/CRISPR

CRISPR & Genome Engineering Conference May 26-27, 2016, Boston, MA ( 9:00 am )

CRISPR & Genome Engineering Conference May 26-27, 2016, Boston, MA

On behalf of GTCbio and the 2016 Advisory Board, you are invited to the CRISPR & Genome Engineering Conference which takes place May 26-27, 2016 in Boston, MA. This meeting is part of The Genomics & Big Data Summit and will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and discuss the most recent advances in CRISPR & Genome Engineering.

Leading researchers will present on hot topics such as: therapeutic applications of CRISPR and genome engineering, discovery and mechanisms of CRISPR systems, and will discuss updates on current CRISPR technologies and techniques. In addition to scientific talks, dedicated networking sessions will allow attendees to better dialogue on how CRISPR & Genome

Engineering will continue to impact biomedical research.

Sessions include:

I. Therapeutic Applications of CRISPR & Genome Engineering
II. Advances in CRISPR-Cas9 Specificity
III. Discovery and Mechanisms of CRISPR Systems
IV. Update: Current CRISPR Technologies & Techniques
V. CRISPR Regulation of Gene Expression
We look forward to seeing you at the conference!

Conference Dates: May 26-27, 2016

Conference Link: http://www.gtcbio.com/CRISPR

Url: http://www.gtcbio.com/CRISPR